C15orf39

Across TCGA pan-cancer cohorts, C15orf39 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated C15orf39 data layer compared with 23 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher C15orf39 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C15orf39 expression acts as an unfavorable survival marker, although some lineages such as COAD show a favorable association.

THYM, UCEC, and READ are the cancer types where C15orf39 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
UCEC	OS	Median	IV	0.066	0.755	<.001	12	view →
READ	DFS	Median	II,III,IV	0.111	0.800	.001	9	view →
LUAD	OS	Median	All	0.215	0.672	.008	9	view →
COAD	DFS	Median	All	0.922	0.498	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

C15orf39–THYM (OS)

Open the THYM breakdown →